Income Statement Instituto Rosenbusch S.A.

Stocks

ROSE

ARROSE010025

Pharmaceuticals

End-of-day quote Buenos Aires S.E. 21/08/2026			5-day change	1st Jan Change
154.50 ^ARS	-2.22%		-0.96%	-35.76%

08-06	Instituto Rosenbusch S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04-09	Instituto Rosenbusch S.A. Reports Earnings Results for the Full Year Ended December 31, 2025	CI

b0ea6b3254afa4dc.rybQ-figAREzmdWhfjX0q5ch1BVR1rNRKlnU7hluSXA.6G2loYjxQiRUoafWMnKC_f5buGcThuo4QjuM30k6CDjpa5ejkMc4VmX4lA

Published financial data: INSTITUTO ROSENBUSCH S.A.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	782M	1.37B	4.53B	8.27B	6.4B
Total Revenues	782M	1.37B	4.53B	8.27B	6.4B
Cost of Goods Sold, Total	561M	739M	3.23B	4.49B	6.69B
Gross Profit	220M	634M	1.3B	3.79B	-286M
Selling General & Admin Expenses, Total	204M	339M	1.16B	1.85B	2.45B
Other Operating Expenses	-5.14M	28.03M	125M	69.56M	634M
Other Operating Expenses, Total	199M	367M	1.28B	1.92B	3.08B
Operating Income	21.55M	267M	15.78M	1.87B	-3.37B
Interest Expense, Total	-34.61M	-168M	-486M	-626M	-1.65B
Interest And Investment Income	-	-	-	-	229K
Net Interest Expenses	-34.61M	-168M	-486M	-626M	-1.65B
Currency Exchange Gains (Loss)	-58.53M	-102M	785M	-2.66B	556M
Other Non Operating Income (Expenses)	-	-	-	-	-
EBT, Excl. Unusual Items	-71.59M	-3.38M	314M	-1.42B	-4.46B
Gain (Loss) On Sale Of Assets	-	-	315M	-	-
Legal Settlements	-	-	-	-	-
Other Unusual Items	52.03M	13.86M	-	-	-
EBT, Incl. Unusual Items	-19.57M	10.48M	630M	-1.42B	-4.46B
Income Tax Expense	4.33M	24.05M	61.92M	186M	50.87M
Earnings From Continuing Operations	-23.89M	-13.57M	568M	-1.61B	-4.51B
Net Income to Company	-23.89M	-13.57M	568M	-1.61B	-4.51B
Minority Interest	4.32M	5.47M	-4.94M	188M	-83.74M
Net Income - (IS)	-19.57M	-8.1M	563M	-1.42B	-4.6B
Net Income to Common Incl Extra Items	-19.57M	-8.1M	563M	-1.42B	-4.6B
Net Income to Common Excl. Extra Items	-19.57M	-8.1M	563M	-1.42B	-4.6B
Per Share Items
Net EPS - Basic	-0.46	-0.19	13.22	-33.28	-107.95
Basic EPS - Continuing Operations	-0.46	-0.19	13.22	-33.28	-107.95
Basic Weighted Average Shares Outstanding	42.59M	42.59M	42.59M	42.59M	42.59M
Net EPS - Diluted	-0.46	-0.19	13.22	-33.28	-107.95
Diluted EPS - Continuing Operations	-0.46	-0.19	13.22	-33.28	-107.95
Diluted Weighted Average Shares Outstanding	42.59M	42.59M	42.59M	42.59M	42.59M
Normalized Basic EPS	-0.95	0.08	4.5	-16.41	-67.46
Normalized Diluted EPS	-0.95	0.08	4.5	-16.41	-67.46
Payout Ratio	-	-	-	-	-
Supplemental Items
EBITDA	44.7M	317M	123M	2.03B	-3.18B
EBITA	21.55M	268M	23.21M	1.89B	-3.37B
EBIT	21.55M	267M	15.78M	1.87B	-3.37B
Effective Tax Rate - (Ratio)	-22.12	229.42	9.83	-13.14	-1.14
Total Current Taxes	4.33M	24.05M	61.92M	186M	50.87M
Normalized Net Income	-40.42M	3.36M	192M	-699M	-2.87B
Supplemental Operating Expense Items
Advertising Expense	2.23M	3.07M	9.84M	12.69M	10.51M
Marketing Expenses	-	-	-	-	-
Selling and Marketing Expenses	87.34M	163M	511M	830M	906M
General and Administrative Expenses	117M	175M	645M	1.02B	1.54B
Maintenance & Repair Expenses, Total	26.49M	29.04M	97.51M	101M	137M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	56.96M	107M	391M	877M	712M
Total Cash And Short Term Investments	56.96M	107M	391M	877M	712M
Accounts Receivable, Total	145M	243M	705M	1.5B	1.2B
Other Receivables	52.84M	89.01M	659M	344M	732M
Notes Receivable	-	-	-	-	-
Total Receivables	198M	332M	1.36B	1.84B	1.93B
Inventory	298M	526M	2.19B	3.14B	2.61B
Other Current Assets, Total	3.16M	36.06M	16.03M	38.6M	486M
Total Current Assets	556M	1B	3.96B	5.9B	5.73B
Gross Property Plant And Equipment	1.46B	2.87B	9.26B	18.16B	23.62B
Accumulated Depreciation	-1.27B	-2.54B	-8.19B	-16.53B	-21.63B
Net Property Plant And Equipment	186M	328M	1.06B	1.63B	1.99B
Long-term Investments	-	-	-	-	-
Other Intangibles, Total	48.43K	3.25M	13.48M	0	0
Other Long-Term Assets, Total	5.6M	15.01M	7.43M	15.82M	20.36M
Total Assets	747M	1.35B	5.04B	7.54B	7.75B
Liabilities
Accounts Payable, Total	88.14M	139M	825M	493M	762M
Accrued Expenses, Total	100M	286M	341M	1.42B	3.85B
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	18.85M	48.89M	436M	947M	519M
Current Income Taxes Payable	6.85M	36.62M	78.37M	35.72M	101M
Other Current Liabilities	64.44M	36M	207M	391M	1.37B
Total Current Liabilities	278M	546M	1.89B	3.29B	6.61B
Long-Term Debt	172M	296M	598M	793M	931M
Deferred Tax Liability Non Current	13.27M	13.27M	13.27M	13.27M	13.27M
Other Non Current Liabilities	84.35M	92.14M	456M	412M	722M
Total Liabilities	548M	947M	2.95B	4.51B	8.27B
Common Stock, Total	42.59M	42.59M	42.59M	42.59M	42.59M
Additional Paid In Capital	-	-	-	-	-
Retained Earnings	-229M	-453M	-849M	-3.27B	-8.89B
Comprehensive Income and Other	363M	774M	2.72B	6.07B	8.05B
Total Common Equity	177M	363M	1.91B	2.84B	-800M
Minority Interest	22.17M	37.71M	174M	191M	274M
Total Equity	199M	401M	2.09B	3.03B	-526M
Total Liabilities And Equity	747M	1.35B	5.04B	7.54B	7.75B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	42.59M	42.59M	42.59M	42.59M	42.59M
ECS Total Common Shares Outstanding	42.59M	42.59M	42.59M	42.59M	42.59M
Book Value / Share	4.16	8.52	44.95	66.74	-18.79
Tangible Book Value	177M	360M	1.9B	2.84B	-800M
Tangible Book Value Per Share	4.16	8.44	44.64	66.74	-18.79
Total Debt	191M	345M	1.03B	1.74B	1.45B
Net Debt	134M	238M	643M	863M	738M
Minority Interest, Total (Incl. Fin. Div)	22.17M	37.71M	174M	191M	274M
Account Code - Inventory Valuation	3	3	3	3	3
Inventories - Raw Materials, Total	141M	231M	1.2B	1.33B	1.23B
Inventories - Work In Process, Total	47.15M	43.98M	173M	348M	556M
Inventories - Finished Goods, Total	110M	226M	816M	1.39B	822M
Inventories - Others	-	25.47M	-	66.4M	-
Machinery, Total	792M	1.59B	5.07B	10.24B	13.11B
Accumulated Allowance for Doubtful Accounts (Supple)	7.02M	5.91M	39.04M	27.67M	37.09M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-19.57M	-8.1M	563M	-1.42B	-4.6B
Depreciation & Amortization - CF	23.15M	48.9M	99.46M	143M	192M
Amortization of Goodwill and Intangible Assets - (CF)	-	1.13M	7.43M	17.31M	-
Depreciation & Amortization, Total	23.15M	50.03M	107M	161M	192M
Amortization of Deferred Charges, Total - (CF)	48.43K	94.34K	-	-	-
Minority Interest in Earnings - (CF)	-4.32M	-5.47M	56.42M	-188M	23.1M
Asset Writedown & Restructuring Costs	-	249K	77.15M	763M	-
Other Operating Activities, Total	9.37M	32.3M	88.24M	-132M	29.61M
Change In Accounts Receivable	50.97M	39.85M	52.64M	34.73M	784M
Change In Inventories	156M	53.79M	-548M	1.62B	1.52B
Change In Accounts Payable	-68.98M	-18.41M	336M	-1.34B	435M
Change In Income Taxes	-58.72M	62.92M	-324M	-238M	1.87B
Change In Deferred Taxes	54.07M	-84.27M	201M	-	-104M
Change in Other Net Operating Assets	-112M	-73.74M	-457M	1.28B	263M
Cash from Operations	29.97M	49.25M	152M	548M	410M
Capital Expenditure	-2.14M	-26.54M	-53.02M	-10.37M	-12.13M
Investment in Marketable and Equity Securities, Total	-	-	-	-	-
Cash from Investing	-2.14M	-26.54M	-53.02M	-10.37M	-12.13M
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Long-Term Debt Repaid, Total	-43.17M	-27.07M	-40.32M	-511M	-839M
Total Debt Repaid	-43.17M	-27.07M	-40.32M	-511M	-839M
Common Dividends Paid	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Cash from Financing	-43.17M	-27.07M	-40.32M	-511M	-839M
Net Change in Cash	-15.35M	-4.35M	58.84M	26.14M	-442M
Supplemental Items
Levered Free Cash Flow	-39.3M	155M	-1.12B	2.86B	1.63B
Unlevered Free Cash Flow	-17.67M	260M	-814M	3.25B	2.66B
Change In Net Working Capital	52.19M	-69.29M	877M	-1.93B	-4.59B
Net Debt Issued / Repaid	-43.17M	-27.07M	-40.32M	-511M	-839M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	1.52	11.91	0.21	12.62	-23.84
Return on Total Capital	3.18	22.19	0.36	20.2	-58.46
Return On Equity %	-11.32	-3.44	34.05	-42.35	-260.63
Return on Common Equity	-10.48	-2.29	36.98	-40.43	-312.88
Margin Analysis
Gross Profit Margin %	28.19	46.16	28.65	45.75	-4.47
SG&A Margin	26.09	24.66	25.53	22.31	38.24
EBITDA Margin %	5.72	23.1	2.71	24.55	-49.61
EBITA Margin %	2.76	19.54	0.51	22.81	-52.61
EBIT Margin %	2.76	19.46	0.35	22.61	-52.61
Income From Continuing Operations Margin %	-3.06	-0.99	12.54	-19.4	-70.49
Net Income Margin %	-2.5	-0.59	12.43	-17.13	-71.8
Net Avail. For Common Margin %	-2.5	-0.59	12.43	-17.13	-71.8
Normalized Net Income Margin	-5.17	0.24	4.23	-8.45	-44.87
Levered Free Cash Flow Margin	-5.03	11.26	-24.68	34.54	25.44
Unlevered Free Cash Flow Margin	-2.26	18.93	-17.97	39.27	41.55
Asset Turnover
Asset Turnover	0.88	0.98	0.98	0.89	0.72
Fixed Assets Turnover	3.9	3.98	4.34	4.19	3.1
Receivables Turnover (Average Receivables)	4.57	5.22	6.19	5.45	4.04
Inventory Turnover (Average Inventory)	1.49	1.34	1.69	1.14	1.99
Short Term Liquidity
Current Ratio	2	1.83	2.1	1.79	0.87
Quick Ratio	0.92	0.8	0.93	0.83	0.4
Operating Cash Flow to Current Liabilities	0.11	0.09	0.08	0.17	0.06
Days Sales Outstanding (Average Receivables)	79.78	69.97	58.95	67.13	90.32
Days Outstanding Inventory (Average Inventory)	244.23	273.13	216.1	322.03	183.73
Average Days Payable Outstanding	113.16	82.66	60.73	146.32	49.79
Cash Conversion Cycle (Average Days)	210.85	260.44	214.32	242.84	224.26
Long Term Solvency
Total Debt/Equity	95.88	86.12	49.51	57.38	-275.57
Total Debt / Total Capital	48.95	46.27	33.11	36.46	156.96
LT Debt/Equity	86.41	73.92	28.64	26.15	-176.94
Long-Term Debt / Total Capital	44.12	39.71	19.16	16.62	100.78
Total Liabilities / Total Assets	73.35	70.29	58.59	59.78	106.79
EBIT / Interest Expense	0.62	1.59	0.03	2.99	-2.04
EBITDA / Interest Expense	1.29	1.88	0.25	3.25	-1.92
(EBITDA - Capex) / Interest Expense	1.23	1.73	0.14	3.23	-1.93
Total Debt / EBITDA	4.27	1.09	8.43	0.86	-0.46
Net Debt / EBITDA	3	0.75	5.24	0.42	-0.23
Total Debt / (EBITDA - Capex)	4.49	1.19	14.84	0.86	-0.45
Net Debt / (EBITDA - Capex)	3.15	0.82	9.23	0.43	-0.23
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-7.3	-9.82	5.9	-16.08	-41.17
Gross Profit, 1 Yr. Growth %	-24.1	47.66	-34.28	34.04	-105.74
EBITDA, 1 Yr. Growth %	-63.21	264.32	-87.24	1.34K	-221.2
EBITA, 1 Yr. Growth %	-77.57	539.14	-97.35	-1.06K	-255.37
EBIT, 1 Yr. Growth %	-77.57	536.54	-98.2	5.34K	-236.91
Earnings From Cont. Operations, 1 Yr. Growth %	12.89	-70.85	-1.44K	-229.8	113.77
Net Income, 1 Yr. Growth %	-23.75	-78.76	-2.33K	-215.62	146.6
Normalized Net Income, 1 Yr. Growth %	-16.91K	-104.27	411.75	-267.48	212.54
Diluted EPS Before Extra, 1 Yr. Growth %	-23.75	-78.76	-2.33K	-215.62	146.6
Accounts Receivable, 1 Yr. Growth %	-25.96	-14.08	-6.95	-2.26	-39.45
Inventory, 1 Yr. Growth %	-34.31	-9.27	33.43	-34.12	-36.81
Net Property, Plant and Equip., 1 Yr. Growth %	-13.95	-9.11	4.09	-29.74	-7.03
Total Assets, 1 Yr. Growth %	-26.72	-7.4	20.13	-31.32	-21.93
Tangible Book Value, 1 Yr. Growth %	-9.87	4.3	69.78	-31.34	-121.4
Common Equity, 1 Yr. Growth %	-9.89	5.21	69.45	-31.82	-121.4
Cash From Operations, 1 Yr. Growth %	-54.44	-15.63	-0.78	65.24	-43.1
Capital Expenditures, 1 Yr. Growth %	-28.32	535.23	-35.84	-91.01	-11.08
Levered Free Cash Flow, 1 Yr. Growth %	-232.62	-160.81	103.59	-168.35	-19.09
Unlevered Free Cash Flow, 1 Yr. Growth %	-129.29	-222.52	268.16	-192.3	5.26
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	18.07	27.61	72.45	39.11	-19.41
Gross Profit, 2 Yr. CAGR %	8.12	47.76	73.84	38.5	-68.18
EBITDA, 2 Yr. CAGR %	32.42	61.6	18.69	45.38	374.25
EBITA, 2 Yr. CAGR %	-30.41	67.13	-25.65	46.89	313.53
EBIT, 2 Yr. CAGR %	-30.42	66.78	-38.68	46.19	890.1
Earnings From Cont. Operations, 2 Yr. CAGR %	-54.42	-19.93	249.3	516.35	91.06
Net Income, 2 Yr. CAGR %	-59.86	-43.83	284.26	649.7	93.66
Normalized Net Income, 2 Yr. CAGR %	-27.02	273.93	56	332.02	162.41
Diluted EPS Before Extra, 2 Yr. CAGR %	-59.86	-43.83	284.26	649.7	93.66
Accounts Receivable, 2 Yr. CAGR %	5.73	11.32	57.79	40.73	-11.77
Inventory, 2 Yr. CAGR %	-1.82	7.75	94.16	38.35	-26
Net Property, Plant and Equip., 2 Yr. CAGR %	8.64	23.42	71.64	26.19	-7.3
Total Assets, 2 Yr. CAGR %	5.1	14.97	86.12	34.04	-16.02
Tangible Book Value, 2 Yr. CAGR %	11.36	35.32	134.83	59.33	-56.04
Common Equity, 2 Yr. CAGR %	11.38	35.9	135.63	58.62	-56.19
Cash From Operations, 2 Yr. CAGR %	-28.85	-13.47	61.46	88.95	11.22
Capital Expenditures, 2 Yr. CAGR %	-53.31	197.82	256.25	-64.57	-67.58
Levered Free Cash Flow, 2 Yr. CAGR %	12.84	128.4	109.64	128.2	-37.58
Unlevered Free Cash Flow, 2 Yr. CAGR %	4.14	107.53	95.86	283.43	-13.06
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	37.77	34.79	75.12	75.82	14.41
Gross Profit, 3 Yr. CAGR %	38.06	49.81	64.71	106.62	-47.47
EBITDA, 3 Yr. CAGR %	2.22	131.74	0.32	185.72	48.97
EBITA, 3 Yr. CAGR %	-16.22	82.01	-37.72	255.6	56.74
EBIT, 3 Yr. CAGR %	-16.22	81.75	-45.23	254.53	56.72
Earnings From Cont. Operations, 3 Yr. CAGR %	35.73	-50.96	199.37	225.5	374.49
Net Income, 3 Yr. CAGR %	190.51	-59.45	179.91	233.75	467.04
Normalized Net Income, 3 Yr. CAGR %	426.31	-64.62	827.14	107.04	324.94
Diluted EPS Before Extra, 3 Yr. CAGR %	190.51	-59.45	179.91	233.75	467.04
Accounts Receivable, 3 Yr. CAGR %	5.62	23.22	53.13	74.34	16.41
Inventory, 3 Yr. CAGR %	30.84	19.43	68.97	75.53	16.74
Net Property, Plant and Equip., 3 Yr. CAGR %	32.83	27.84	70.28	65.18	24.88
Total Assets, 3 Yr. CAGR %	26.78	25.83	70.37	73.04	22.65
Tangible Book Value, 3 Yr. CAGR %	11.48	36.08	113.13	102.02	-10.59
Common Equity, 3 Yr. CAGR %	11.49	36.49	113.6	102.01	-10.86
Cash From Operations, 3 Yr. CAGR %	10.75	-5.95	32.26	110.9	38.77
Capital Expenditures, 3 Yr. CAGR %	12.48	39.21	160.71	35.42	-47.24
Levered Free Cash Flow, 3 Yr. CAGR %	56.8	71.1	235.32	124.02	43.71
Unlevered Free Cash Flow, 3 Yr. CAGR %	-3.76	151.72	138.02	148.35	129.19
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	36.11	38.04	72.22	71.32	50
Gross Profit, 5 Yr. CAGR %	29.6	68	72.99	82.21	-0.3
EBITDA, 5 Yr. CAGR %	18.4	58.72	24	140.03	92.09
EBITA, 5 Yr. CAGR %	5.44	43.35	-8.73	111.6	103.7
EBIT, 5 Yr. CAGR %	5.44	43.22	-15.5	111.21	103.7
Earnings From Cont. Operations, 5 Yr. CAGR %	15.43	-21.27	126.36	69.41	192.27
Net Income, 5 Yr. CAGR %	14	-29.89	271.25	63.46	182.25
Normalized Net Income, 5 Yr. CAGR %	40.25	-31.06	269.75	55.9	553.85
Diluted EPS Before Extra, 5 Yr. CAGR %	14	-29.89	271.25	63.46	182.25
Accounts Receivable, 5 Yr. CAGR %	17.43	18.89	41.71	63.09	43.51
Inventory, 5 Yr. CAGR %	33.44	34.61	75.07	58.97	41.9
Net Property, Plant and Equip., 5 Yr. CAGR %	42.09	31.12	68.16	59.62	56
Total Assets, 5 Yr. CAGR %	30.45	29.79	68.91	61.97	50
Tangible Book Value, 5 Yr. CAGR %	18.5	18.54	71.61	81.91	32.44
Common Equity, 5 Yr. CAGR %	18.5	18.75	71.85	81.91	32.43
Cash From Operations, 5 Yr. CAGR %	13.6	69.58	47.15	56.03	44.18
Capital Expenditures, 5 Yr. CAGR %	-32.89	54.51	103.83	1.07	32.32
Levered Free Cash Flow, 5 Yr. CAGR %	16.6	11.7	155.83	147.36	122.86
Unlevered Free Cash Flow, 5 Yr. CAGR %	4.21	23.93	110.21	188.37	113.25